Blood cell count in antipsychotic-naive patients with non-affective psychosis.

WBC count drug naïve metabolic disturbances metabolic syndrome monocyte count neutrophil count non-affective psychosis schizophrenia

Journal

Early intervention in psychiatry
ISSN: 1751-7893
Titre abrégé: Early Interv Psychiatry
Pays: Australia
ID NLM: 101320027

Informations de publication

Date de publication:
02 2019
Historique:
received: 17 10 2016
revised: 20 02 2017
accepted: 25 04 2017
pubmed: 9 8 2017
medline: 23 7 2019
entrez: 9 8 2017
Statut: ppublish

Résumé

Schizophrenia is a complex medical entity with a reduced life expectancy, mostly due to an increased prevalence of cardiovascular diseases compared to the general population. An unbalanced immune response and a pro-inflammatory state might underlie this process. In treated patients, abnormal white blood cell (WBC), lymphocyte and neutrophil count suggests atypical immune response related to clinical variables. We aimed to test the hypothesis that newly diagnosed naïve patients with non-affective psychosis would show abnormal blood cell count values after controlling for potential confounding factors compared to matched controls. Seventy-five patients were compared with 80 controls matched for age, gender, body mass index and smoking. Analyses were conducted before and after controlling for smoking. Patients and controls displayed similar mean values (×10 These results suggest that abnormal immune response is present before the effects of medication and other confounders had taken place. Increased immune parameters might underlie the high ratio of medical co-morbidities described in schizophrenia.

Sections du résumé

BACKGROUND
Schizophrenia is a complex medical entity with a reduced life expectancy, mostly due to an increased prevalence of cardiovascular diseases compared to the general population. An unbalanced immune response and a pro-inflammatory state might underlie this process. In treated patients, abnormal white blood cell (WBC), lymphocyte and neutrophil count suggests atypical immune response related to clinical variables. We aimed to test the hypothesis that newly diagnosed naïve patients with non-affective psychosis would show abnormal blood cell count values after controlling for potential confounding factors compared to matched controls.
METHODS
Seventy-five patients were compared with 80 controls matched for age, gender, body mass index and smoking. Analyses were conducted before and after controlling for smoking.
RESULTS
Patients and controls displayed similar mean values (×10
CONCLUSIONS
These results suggest that abnormal immune response is present before the effects of medication and other confounders had taken place. Increased immune parameters might underlie the high ratio of medical co-morbidities described in schizophrenia.

Identifiants

pubmed: 28786532
doi: 10.1111/eip.12456
doi:

Substances chimiques

Antipsychotic Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

95-100

Subventions

Organisme : NIDDK NIH HHS
ID : RO1 DK069265
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK069265
Pays : United States

Informations de copyright

© 2017 John Wiley & Sons Australia, Ltd.

Auteurs

Clemente Garcia-Rizo (C)

Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic, Barcelona, Spain.
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain.

Marta Casanovas (M)

Department of Psychiatry, Vall d'Hebron University Hospital, Autonomous University of Barcelona, Barcelona, Spain.

Emilio Fernandez-Egea (E)

Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain.
Department of Psychiatry, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
Cambridgeshire and Peterborough NHS Foundation Trust, Huntingdon, UK.

Cristina Oliveira (C)

Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic, Barcelona, Spain.

Ana Meseguer (A)

Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic, Barcelona, Spain.

Bibiana Cabrera (B)

Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic, Barcelona, Spain.
Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain.

Gisela Mezquida (G)

Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic, Barcelona, Spain.

Miquel Bioque (M)

Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic, Barcelona, Spain.
Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain.

Brian Kirkpatrick (B)

Department of Psychiatry and Behavioral Sciences, University of Nevada School of Medicine, Reno, Nevada.

Miquel Bernardo (M)

Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic, Barcelona, Spain.
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
Centre for Biomedical Research in the Mental Health Network (CIBERSAM), Madrid, Spain.
Department of Medicine, University of Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH